Healthcare - Biotechnology - NASDAQ - US
$ 14.37
-0.76 %
$ 101 M
Market Cap
-0.6
P/E
Price Target
Average
67.01%
Revenue Forecast
Estimate
--1.45%
EBIT
Estimate
--16.65%
Net Income
Estimate
2.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cidara Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CDTX of $24 , with forecasts ranging from a low of $24 to a high of $24 .
CDTX Lowest Price Target
Wall Street Target
24 USD
67.01%
CDTX Average Price Target
Wall Street Target
24 USD
67.01%
CDTX Highest Price Target
Wall Street Target
24 USD
67.01%
REVENUE FORECAST
Revenue Forecast Chart CDTX
EBIT FORECAST
EBIT Forecast Chart CDTX
NET INCOME FORECAST
Net Income Chart CDTX